Diane Pannier

Lille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study.

Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study.

Journal: British journal of cancer
Published: June 25, 2025

Development and evaluation of a new protocol for the management of immediate hypersensitivity reactions in an oncology outpatient department.

Development and evaluation of a new protocol for the management of immediate hypersensitivity reactions in an oncology outpatient department.

Journal: Bulletin du cancer
Published: November 07, 2024

A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse.

A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 19, 2024

Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial.

Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial.

Journal: Nature medicine
Published: January 26, 2024

Early palliative care and overall survival in patients with metastatic upper gastrointestinal cancers (EPIC): a multicentre, open-label, randomised controlled phase 3 trial.

Early palliative care and overall survival in patients with metastatic upper gastrointestinal cancers (EPIC): a multicentre, open-label, randomised controlled phase 3 trial.

Journal: EClinicalMedicine
Published: November 10, 2023

Should we take into account the informational stress of the medical oncologist?

Should we take into account the informational stress of the medical oncologist?

Journal: Bulletin du cancer
Published: November 09, 2023

Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).

Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: April 19, 2023

Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value.

Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value.

Journal: International journal of cancer
Published: December 02, 2022

Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.

Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.

Journal: The Lancet. Oncology
Published: January 10, 2022

PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.

PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.

Journal: Cancer discovery
Published: May 26, 2021

Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study.

Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study.

Journal: Cancer chemotherapy and pharmacology
Published: October 06, 2020

Withholding or withdrawing life-sustaining treatments in acute oncology situations: History and regulatory aspects in France

Withholding or withdrawing life-sustaining treatments in acute oncology situations: History and regulatory aspects in France

Journal: Bulletin du cancer
Published: July 02, 2020
Showing 1-12 of 27

Last Updated: 09/26/2026